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“There is more than one way to skin a cat”, an old proverb says. 
Scientists know this well (metaphorically speaking, of course), as they 
often face complex challenges that require creative, out-of-the-box 
thinking, and are usually praised for their problem-solving skills.
The issue, however, is when these creative minds are faced with 
non-significant findings of their meticulously performed research; 
and, then, after ingenuity and art, obtain positive findings: in some 
cases, outliers are “rightfully” excluded and replaced by new data; 
in others, dozens of tests are run until, “out of serendipity”, that 
association (never thought before) suddenly fits with the mainstream 
theory. Some data just needed to be handled more carefully, treated 
more softly, discussed more thoughtfully, to stand a chance in this 
wild world of peer reviewing and publishing. In fact, although “God 
loves the [p=]0.06 as much as the 0.05”1, editors, reviewers and grant 
committees still love the latter much, much more2.
The result of this mixed bag of controversial approaches to the 
data, driven by academic pressures and collectively described as 
“p-hacking”2, has been detrimental to both basic and applied science, 
as it leads to an overinflation of false-positive – and, hence, non-
replicable – findings. In psychology, a consortium of several research 
groups recently aimed to replicate 100 highly representative studies 
published in leading journals. The authors found that only one third 
of the replication studies had significant findings (vs. 97% of original 
studies) and the mean effect size of the replication studies was half 
the magnitude of the original studies3. Research that uses statistical 
methods to detect excess significance is also revealing. In a systematic 
review of meta-analyses investigating brain volume abnormalities, the 
mean effect size of each meta-analysis was employed to estimate the 
power to detect an alpha at 0.05 and then to estimate the number of 
expected positive datasets. The author found that there were too many 
studies with statistically significant results in the literature on brain 
volume abnormalities4, which strongly suggests publication bias and/
or p-hacking. A similar approach was used in psychotherapy studies, 
showing that the effect sizes of the psychotherapy interventions were 
overestimated, and that the literature had an unexpected high number 
(excessive) of positive findings according to the obtained evidence5. 
In another approach, Head et al.2 used the p-curve to assess 
the reliability of published research. When the true effect of an 
investigated phenomenon is zero (true negative), each p value has 
an equal probability to occur (i.e., p = 0.04 is as likely as p = 0.03), 
whereas in true positive findings the p-curve right skews (i.e., has 
more smaller values) as the effect increases. In both cases, the p-curve 
shape will be changed if there is evidence of p-hacking. The typical 
pattern is an increased frequency of p-values just below 0.05, when 
researchers stop their efforts to obtain significant findings. The 
authors used text-mining techniques to extract p values from all 
open access papers available in PubMed, finding strong evidence 
for p-hacking across all disciplines. For instance, approximately 
50% and 60% of studies in the medical and psychological sciences, 
respectively, had p-values between 0.045 and 0.05, “just in the limit” 
of significance. They concluded that p-hacking is widespread in 
scientific literature2.
What can scientists do, therefore, to mitigate the p-hacking 
plague from our fields? Unfortunately, there is no single solution 
for this complex problem. There is still too much emphasis in the 
p-value, whereas more informative statistics, such as the effect size 
and its surrounding confidence interval, are usually neglected. In 
fact, the p-value only informs the probability of obtaining an equal 
or more extreme effect, given the null hypothesis is true. In fact, the 
pre-test probability (i.e., prior likelihood of the phenomenon) is the 
main determinant for rejecting a false negative finding6. Nonetheless, 
and in spite of having or not theoretical knowledge, editors, authors 
and policy-makers often simplify the p-value as being the probability 
of a true effect (i.e., of neglecting the null hypothesis). On the other 
hand, p-values > 0.05 are also informative in studies that were well-
designed, powered, and robust to biases regarding sample selection, 
masking, performance and attrition7.   
Therefore, results should be contextually interpreted and, hence, 
a detailed description of the study design is crucial to critically assess 
its methodology. Interestingly, although the CONSORT statement 
emphasizes this need8, studies are still insufficiently described in 
most fields9; possibly due to editorial restrictions regarding article 
size. Thus, publications of only study protocol and design are useful, 
which also allow assessment of study methodology separately and 
independently of the obtained results. Most importantly, though, is 
the a priori statement of the main research question, the primary 
and secondary hypotheses, and the planned statistical analyses. 
Authors are naturally not impeded to perform post hoc analyses, 
which also have its exploratory and hypothesis-generating value. In 
addition, new and important research questions might arise during 
an ongoing study that were not initially planned – for instance, a 
new neuroimaging analysis method that was not at first available 
or simply did not exist at study start. Researchers should and must 
explore novel research tracks – and also be transparent regarding a 
priori and post hoc hypotheses, a goal that study design publication 
can help to accomplish.
Considering these challenges, the Archives of Clinical Psychiatry 
issues a call to action for authors to publish the design, protocol and 
preliminary findings of their studies in the journal. We believe that 
this is one of the necessary steps to increase transparency, decrease 
p-hacking and tackle the reproducibility issues that ravage clinical 
neuroscience and psychiatry. The Archives of Clinical Psychiatry, an 
open access, peer review journal, welcomes authors to share their 
study protocols and methodology. Therefore, dear author, please let 
us know, in excruciating details, how you plan to skin your next cat. 
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